Display options
Cite
Kosan B, Steger V, Walker T, et al. Surgery of pulmonary aspergillomas in immunocompromised patients. Thorac Surg Sci. 2010;7:Doc01doi: 10.3205/tss000020.
Kosan, B., Steger, V., Walker, T., Friedel, G., & Aebert, H. (2010). Surgery of pulmonary aspergillomas in immunocompromised patients. Thoracic surgical science, 7Doc01. https://doi.org/10.3205/tss000020
Kosan, B, et al. "Surgery of pulmonary aspergillomas in immunocompromised patients." Thoracic surgical science vol. 7 (2010): Doc01. doi: https://doi.org/10.3205/tss000020
Kosan B, Steger V, Walker T, Friedel G, Aebert H. Surgery of pulmonary aspergillomas in immunocompromised patients. Thorac Surg Sci. 2010 Mar 10;7:Doc01. doi: 10.3205/tss000020. PMID: 21289887; PMCID: PMC3010893.
Copy Download .nbib Format: NLM
Share it on

Thorac Surg Sci. 2010 Mar 10;7:Doc01. doi: 10.3205/tss000020.

Surgery of pulmonary aspergillomas in immunocompromised patients.

Thoracic surgical science

B Kosan, V Steger, T Walker, G Friedel, H Aebert

Affiliations

  1. Department of Thoracic Surgery, Schillerhoehe Hospital, Gerlingen, Germany.

PMID: 21289887 PMCID: PMC3010893 DOI: 10.3205/tss000020

Abstract

INTRODUCTION: Pulmonary aspergillosis is a devastating complication in immunocompromised patients. Timing of surgery is controversial and depends on the patients' general condition.

METHODS: From 2000 to 2007, 16 patients (mean age 47 years, range 20-64) underwent surgery for pulmonary aspergillosis. All patients were receiving immunosuppressive drugs due to chemotherapy of hematological malignancies, ten with additional bone marrow or stem cell transplantation. Perioperatively, aspergillosis was treated with antifungal agents. If granulocyte numbers in the peripheral blood was below 1.0x10(9)/l, granulocyte stimulating factor and granulocyte transfusions were administered perioperatively.

RESULTS: Four patients underwent lobectomy and wedge resections of the same lung, one patient bilobectomy, two patients lobectomy, eight patients wedge resections of one lung, and one patient wedge resections of both lungs. All patients survived surgery without major complications. Five patients were bone marrow or stem cell transplanted 1, 2, 3, 7 and 10 months after surgery. Three of them died due to recurrence of the underlying malignancy. All other patients are alive and free of fungal disease.

CONCLUSIONS: Timing of surgery in the context of antifungal therapy and adequate numbers of granulocytes and platelets in the peripheral blood appear essential for successful surgical therapy and avoidance of major complications.

Keywords: bone marrow transplantation; hematological malignancies; immunosuppression; pulmonary aspergillosis; thoracic surgery

References

  1. J Thorac Cardiovasc Surg. 1995 Jun;109(6):1182-96; discussion 1196-7 - PubMed
  2. Eur J Cardiothorac Surg. 1997 Dec;12(6):876-9 - PubMed
  3. Pathol Annu. 1993;28 Pt 1:231-77 - PubMed
  4. Curr Hematol Rep. 2003 Nov;2(6):522-7 - PubMed
  5. Br J Haematol. 2004 May;125(3):392-9 - PubMed
  6. J Clin Microbiol. 2000 Oct;38(10):3830-3 - PubMed
  7. J Thorac Cardiovasc Surg. 2000 May;119(5):906-12 - PubMed
  8. Chest. 2003 Mar;123(3):929-34 - PubMed
  9. Expert Opin Pharmacother. 2003 May;4(5):807-23 - PubMed
  10. Eur J Cardiothorac Surg. 1992;6(3):138-42; discussion 143 - PubMed
  11. J Clin Microbiol. 2001 Apr;39(4):1626-9 - PubMed
  12. J Clin Microbiol. 2000 Feb;38(2):586-90 - PubMed
  13. Eur Radiol. 2003 Aug;13(8):1786-800 - PubMed
  14. Br J Haematol. 2000 Nov;111(2):635-40 - PubMed
  15. J Antimicrob Chemother. 2002 Feb;49 Suppl 1:43-7 - PubMed
  16. Chest. 2004 Jan;125(1):260-71 - PubMed
  17. Thorax. 1952 Dec;7(4):317-33 - PubMed
  18. J Thorac Cardiovasc Surg. 1998 Jan;115(1):63-8; discussion 68-9 - PubMed
  19. Lancet. 1998 Oct 31;352(9138):1443 - PubMed
  20. Int J Hematol. 2002 Aug;76 Suppl 2:77-80 - PubMed
  21. Curr Opin Pulm Med. 2002 May;8(3):195-200 - PubMed
  22. Haematologica. 2004 May;89(5):632-3 - PubMed
  23. Chest. 2002 Sep;122(3):886-92 - PubMed
  24. Ann Thorac Surg. 1998 May;65(5):1415-9 - PubMed
  25. N Engl J Med. 2002 Aug 8;347(6):408-15 - PubMed
  26. Chest. 2002 Jun;121(6):1988-99 - PubMed
  27. Chest. 2002 Apr;121(4):1171-6 - PubMed
  28. J Infect Dis. 2002 Apr 15;185(8):1203-6 - PubMed
  29. J Clin Oncol. 1997 Jan;15(1):139-47 - PubMed
  30. Ann Thorac Surg. 1999 Aug;68(2):321-5 - PubMed
  31. Bone Marrow Transplant. 2000 Oct;26(7):759-62 - PubMed
  32. Clin Infect Dis. 1996 Sep;23(3):608-15 - PubMed
  33. Ann Thorac Surg. 2001 Sep;72(3):889-93; discussion 894 - PubMed
  34. Ann Thorac Surg. 1992 Apr;53(4):621-4 - PubMed
  35. Clin Infect Dis. 2001 Feb 1;32(3):358-66 - PubMed
  36. J Antimicrob Chemother. 2002 Feb;49 Suppl 1:31-6 - PubMed
  37. Hematol J. 2003;4(1):10-7 - PubMed
  38. Expert Opin Investig Drugs. 2001 Aug;10(8):1545-58 - PubMed
  39. Br J Haematol. 2001 Apr;113(1):180-4 - PubMed

Publication Types